Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Tests Conducted by Product, Animal Type & End-User The global veterinary infectious disease diagnostics market will witness a robust CAGR of 8.9%, valued at $1.76 billion in 2021, expected to appreciate and reach $3.80 billion by 2030, confirms Strategic Market Research. Leaving an infectious disease untreated for an extended period can result in animal fatalities. Therefore, a significant part of treating animals affected by these diseases is to identify these diseases early. Diagnostic procedures and tests are also known as veterinary diagnoses when they detect infectious diseases in animals, and veterinary infectious disease diagnostic products are used for these tests and procedures. Various infectious diseases can be seen in animals such as cats and dogs, using the diagnostics procedures, including viruses, bacteria, and parasites. These procedures use various methods to obtain blood, feces, or tissue samples. In addition, veterinary diagnostics often use new techniques and technologies developed for human diagnostics. In veterinary diagnostics, various methods are used, including immunodiagnostics (lateral flow assays, ELISA, etc.) and molecular diagnostics (PCR tests, microarrays, etc.). Other diagnostic methods are indirect fluorescent antibody tests (IFAT), complement fixation, agglutination, western blot, etc. Impact of Covid-19 on the market:- A moderate impact was felt by the veterinary infectious disease diagnostics market during the COVID 19 pandemic since most countries and states consider pet care/animal care to be an essential service. Consequently, growth did not decrease significantly due to the pandemic. Veterinary practices are considered critical businesses in most countries. These measures allow services to remain open even if pandemics cause restrictions or shutdowns. Many veterinarians experienced a drop in compliance with pet care guidelines during the first few months of the pandemic. However, following the lifting of the lockdown, veterinary services have been substantially restored. Many veterinary services have shown signs of improvement since December 2020. According to AmerisourceBergen Corporation 2020, testing for heartworms (+5%), health exams (+14%), and blood tests for senior wellness (+24%). Also, pet adoption has been on the rise during the COVID-19 pandemic, as the Insurance Research Council published in its October 2020 report that, during the COVID-19 pandemic, almost 30% of Americans adopted a pet. In the United States, about 67% of households have pets, which amounts to about 84.9 million households. With the rise in pet adoption, we can expect positive growth in veterinary infectious disease diagnosis services in the coming years. Market Dynamics - Key Drivers and Restraints of industry- We anticipate that an increase in the prevalence of zoonotic diseases will propel market growth. A disease that spreads between animals and humans is known as a zoonotic disease. The infection can result from viruses, bacteria, parasites, and fungi. Infectious diseases spread through animals to almost 6 in 10 people, according to scientists. In addition, transportation of goods and rapid movement of people has resulted in the introduction and creation of several novel vector species previously absent in some areas. The prevalence of several zoonotic and vector-borne diseases will likely increase soon due to changing social habits, habitat modification, exotic vector introductions, and climate change. As a result, the demand for rapid and precise diagnostic methods to prevent these diseases will fuel veterinary infectious disease diagnostics growth. As per the estimation, the global market for veterinary infectious disease diagnostics will continue to increase because the medical capabilities of companion animals have improved in developed countries, as seen in this forecast. In addition, the market demand for technologically advanced diagnostic methods, such as RTPCR, already exceeds that of conventional diagnostic methods. Market Analysis Of Different Segments Covered in the Report Market segmentations include:- Molecular diagnostics Immunodiagnostics Other technologies A further division of Immunodiagnostics is:- ELISA tests Lateral flow assays Other immunodiagnostic technologies. Immunodiagnostics will dominate the market during the forecast period. Several factors drive this segment’s development, including advances in advanced diagnostics, new immunoassay formats, and diagnostic platforms. As a result, the market primarily focuses on this segment for new product development. By Animal Type, companion animals accounted for the highest share of the market in 2020. In terms of animal type, the market can be segmented into:- Food-producing animals Companion animals The Companion animal segment generated the highest revenue in 2020 and is anticipated to witness growth during the forecast period. This is because of the increasing number of pet owners in developed countries, the growing popularity of pet insurance, the increased number of veterinarians worldwide, and measures that prevent and control animal diseases. Based on end-users, Reference Laboratories dominated the veterinary infectious disease diagnostic market in 2020. Veterinary hospitals Reference laboratories In-house/point-of-care laboratories. Veterinary Infectious Disease Diagnostics Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 1.76 billion Revenue forecast in 2030 USD 3.80 billion Growth rate CAGR of approximately 8.9% Base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Animal Type, By End-User , By Region By Product Immunodiagnostics, Molecular Diagnostics, and Others By Animal Type Companion animals, Food-producing animals By End-User Reference laboratories, Veterinary hospitals, In-house/point-of-care laboratories By Region North America, Europe, Asia-Pacific, LAMEA. Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Neogen Corporation, QIAGEN N.V. (A Part of Indical Bioscience), Randox Laboratories, Ltd., Thermo Fisher Scientific, Virbac, Biomerieux S.A., Heska Corporation, IDEXX Laboratories, Inc., IDVet, Zoetis, Inc. Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Among the end-users, Reference laboratories dominated in the year 2020. In addition, several reference laboratories receive many samples from small and large animal practices for analysis, which can further explain the larger share of this segment. Asia Pacific is expected to grow at the highest CAGR during the forecast period, whereas North America is Expected to Lead the market. Based on the regional analysis, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to maintain its dominant position in the market during the forecast period. A key reason for this dominance is the increased number of products in the market, substantial stakes held by the key players in the region, and the growing affordability and availability of early detection. Over the forecast period, the Asia Pacific market is expected to grow at the highest rate, driven by increasing pet adoptions, zoonotic disease incidences, and the growing demand for infectious disease diagnostics in livestock. Global Veterinary Infectious Disease Diagnostics Market Competitive Landscape Analysis An industry analysis helped identify several growth strategies, including product launch/enhancements, collaborations, and acquisitions employee by market players to enhance their product portfolio and gain a competitive edge in the market. The most widely adopted growth strategies among these business strategies were partnerships and agreements. In 2019, Idexx Laboratories, Inc. (U.S.) dominated the market. A broad range of products offered by the company is integral to the market. It is widely used in essential regions such as Asia Pacific, North America, Africa, and the Middle East. Neogen Corporation QIAGEN N.V. (A Part of Indical Bioscience) Randox Laboratories, Ltd. Thermo Fisher Scientific Virbac Biomerieux S.A. Heska Corporation IDEXX Laboratories, Inc. IDVet Zoetis, Inc. The Latest Recent Developments are:- In January 2020, NEOGEN Corporation acquired ProductosQuimicosMagiar, a distributor of NEOGEN’s food safety diagnostics that deal with animal health in the food industry. It is an expansion of the company’s business in Latin America. In April 2020, Heska Corporation acquired scil animal care company GmbH for USD 110 million, enabling the company to enter more than 25 new countries and position the company in the top 3 places in North America, Europe, Asia Pacific, and Latin America. Furthermore, the company expects to offer a greater variety of products across North America and Europe. Frequently Asked Question About This Report Which are the top companies that hold the market share in the global market? Major companies operating in the market include Biomérieux SA, HESKA Corporation, IDEXX Laboratories, Inc., ID.Vet, Neogen Corporation, Qiagen N.V., Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac, and Zoetis. What are veterinary infectious disease diagnostics? Diagnostic procedures and tests performed on animals are also known as veterinary diagnoses when they detect their infectious diseases. A veterinary infectious disease diagnostic product is also used for these tests and procedures. What are the different types of infections affecting companion animals and food-producing animals? Pets are prone to parasitic infections such as toxoplasmosis. Tinea corporis/capitis (ringworm) are common fungal infections found in pets; campylobacter and salmonellosis are commonly contracted bacterial diseases. It is less common for pets to transmit illnesses caused by arthropods or viruses (e.g., scabies or rabies). What is the veterinary infectious disease diagnostics market growth? The global veterinary infectious disease diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 8.9% from 2021 to 2030 to reach USD3.80 billion by 2030. What is the total value of the market? The total size was valued at $1.76 billion in 2021. What would be the forecast period in the market report? The report’s forecast period is from 2021 to 2030. How big is the veterinary infectious disease diagnostics market? The global veterinary infectious disease diagnostics market size was $1.76 Bn in 2021 and is predicted to reach $3.80 Bn by 2030, with a CAGR of 8.9%. Sources Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Market Segmentation 1.3.2 Geographic Scope Figure 02: Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Market, 2020–2028 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Market, 2020–2028 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Market, 2020–2028(USD Million) 3.1.4 Market Summary Figure 10: Immunodiagnostics to Witness Highest CAGR in Market, By Technology, During Forecast Period Figure 11: Reference laboratories to Witness Higher CAGR in Market for End-User Segment during Forecast Period Figure 12: Companion animal to Witness Higher CAGR in Market for By Animal Type Segment during Forecast Period Figure 13: North America to Account for Largest Share of Global Market In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 14: Market Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Veterinary Infectious Disease Diagnostics Market 5.2.1 Global market, 2020 – 2028 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global market, by region, 2021-2030 (USD Million) 5.4 Product Segment Analysis 5.4.1 Global market, By Technology, 2021-2030 (USD Million) 5.5 End-User Segment Analysis 5.5.1 Global market, By End-User, 2021-2030 (USD Million) 5.6 Value Chain Analysis 5.7 Market Variable Analysis 5.7.1 Market Drivers Analysis 5.7.2 Market Restraints Analysis 5.8 Business Environment Analysis Tool 5.8.1 market PEST analysis 5.8.2 market Porter’s analysis 5.9 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 15 Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 16 Market Drivers and Their Impact 6.2.2 Restraints Figure 17 Market Restraints and Their Impact 6.2.3 Opportunities Figure 18 Market Opportunities and Their Impact 6.2.4 Challenges Figure 19 Market Challenges and Their Impact 6.3 Impact of Covid-19 on Market 6.4 Value Chain Analysis Figure 20 Value Chain Analysis: Market 6.5 Ecosystem Figure 21 Market: Ecosystem Table 3 Market: Ecosystem Figure 22 Revenue Shift in Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Market in USA in Last 9 Years Figure 23 Top 10 Companies with Highest No. of Patents in Last 9 Years Figure 24 No of Patents Granted Per Year, 2019–2020 Table 5 List of Global Patents in Market 6.7 Trade Analysis 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 6: Market: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 By Animal Type Analysis 6.11.1 Trends in By Animal Type (2014-2020) 6.11.2 Trends in By Animal Type (2021-2028) Table 7 Key Regulations: Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 8: Key Players market share Figure 25: Key players market share of companies 7.2 Manufacturers Manufacturing Sites, Area Served, Product 7.3 Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Market: Technology Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2021-2030) Table 9 Market, By Technology, 2021–2028 (USD Million) Figure 26 Market, By Technology Figure 27 Immunodiagnostics Segment to Register Highest CAGR in the Market During Forecast Period 8.3 Immunodiagnostics 8.3.1 Immunodiagnostics market, 2021-2030 (USD Million) 8.3.1.1 Lateral flow assays market, 2021-2030 (USD Million) 8.3.1.2 ELISA tests market, 2021-2030 (USD Million) 8.3.1.3 Other immunodiagnostic technologies market, 2021-2030 (USD Million) Figure 28: Immunodiagnostics market, 2021-2030 (USD Million) 8.4 Molecular diagnostics 8.4.1 Molecular diagnostics market, 2021-2030 (USD Million) Figure 29: Molecular diagnostics market, 2021-2030 (USD Million) Chapter 9. Global Market: End-User Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2021-2030) Table 10: Market, By End-User, 2021–2028 (USD Million) Figure 30: Market, By End-User, 2021–2028 (USD Million) Figure 31: Reference laboratories Segment to Register Highest CAGR in the Market during Forecast Period 9.3 Reference laboratories 9.3.1 Reference laboratories market, 2021-2030 (USD Million) Figure 32: Reference laboratories market, 2021-2030 (USD Million) 9.4 Veterinary hospitals 9.4.1 Veterinary hospitals market, 2021-2030 (USD Million) Figure 33: Veterinary hospitals market, 2021-2030 (USD Million) 9.5 In-house/point-of-care laboratories 9.5.1 In-house/point-of-care laboratories market, 2021-2030 (USD Million) Figure 34: In-house/point-of-care laboratories market, 2021-2030 (USD Million) Chapter 10. Global Market: By Animal Type Segment Analysis 10.1 Introduction 10.2 Sales Volume & Revenue Analysis (2021-2030) Table 11 Market, By By Animal Type, 2021–2028 (USD Million) Figure 35 Market, By By Animal Type Figure 36 Companion animals Segment to Register Highest CAGR in the Market During Forecast Period 10.3 Companion animals 10.3.1 Companion animals market, 2021-2030 (USD Million) Figure 37: Companion animals market, 2021-2030 (USD Million) 10.4 Food-producing animals 10.4.1 Food-producing animals market, 2021-2030 (USD Million) Figure 38: Food-producing animals market, 2021-2030 (USD Million) Chapter 11. Global Market: Regional Outlook 11.1 North America Figure 39: North America Market, By Revenue Forecast (2021-2030) 11.1.1 North America market, by country, 2021-2030 (USD Million) Table 12: North America Market, by Country, 2021-2030 Figure 40: North America Market 11.1.2 North America market, By Technology, 2021-2030 (USD Million) Table13: North America market, By Technology, 2021-2030 (USD Million) Figure 41: North America market, By Technology, 2021-2030 (USD Million) 11.1.3 North America market, by End-User, 2021-2030 (USD Million) Table 14: North America market, by End-User, 2021-2030 (USD Million) Figure 42: North America market, by End-User, 2021-2030 (USD Million) 11.1.4 U.S. 11.1.4.1 U.S. market, By Technology, 2021-2030 (USD Million) Figure 43: U.S. market, By Technology, 2021-2030 (USD Million) 11.1.4.2 U.S. market, by End-User, 2021-2030 (USD Million) Figure 44: U.S. market, by End-User, 2021-2030 (USD Million) 11.1.5 Canada 11.1.5.1 Canada market, By Technology, 2021-2030 (USD Million) Figure 45: Canada market, By Technology, 2021-2030 (USD Million) 11.1.5.2 Canada market, by End-User, 2021-2030 (USD Million) Figure 46: Canada market, by End-User, 2021-2030 (USD Million) Figure 47: Canada market, by End-User, 2021-2030 (USD Million) Figure 48: Canada market, by End-User, 2021-2030 (USD Million) 11.2 Europe Figure 49: Europe Market, By Revenue Forecast (2021-2030) 11.2.1 Europe market, by country, 2021-2030 (USD Million) Table 15: Europe market, by country, 2021-2030 (USD Million) Figure 50: Europe market, by country, 2021-2030 (USD Million) 11.2.2 Europe market, By Technology, 2021-2030 (USD Million) Table 16: Europe market, By Technology, 2021-2030 (USD Million) Figure 51: Europe market, By Technology, 2021-2030 (USD Million) 11.2.3 Europe market, by End-User, 2021-2030 (USD Million) Table 17: Europe market, by End-User, 2021-2030 (USD Million) Figure 52: Europe market, by End-User, 2021-2030 (USD Million) 11.2.4 U.K. 11.2.4.1 U.K. market, By Technology, 2021-2030 (USD Million) Figure 53: U.K. market, By Technology, 2021-2030 (USD Million) 11.2.4.2 U.K. market, by End-User, 2021-2030 (USD Million) Figure 54: U.K. market, by End-User, 2021-2030 (USD Million) 11.2.5 Germany 11.2.5.1 Germany market, By Technology, 2021-2030 (USD Million) Figure 55: Germany market, By Technology, 2021-2030 (USD Million) 11.2.5.2 Germany market, by End-User, 2021-2030 (USD Million) Figure 56: Germany market, by End-User, 2021-2030 (USD Million) 11.2.6 France 11.2.6.1 France market, By Technology, 2021-2030 (USD Million) Figure 57: France market, By Technology, 2021-2030 (USD Million) 11.2.6.2 France market, by End-User, 2021-2030 (USD Million) Figure 58: France market, by End-User, 2021-2030 (USD Million) 11.2.7 Rest of Europe 11.2.7.1 Rest of Europe market, By Technology, 2021-2030 (USD Million) Figure 59: Rest of Europe market, By Technology, 2021-2030 (USD Million) 11.2.7.2 Rest of Europe market, by End-User, 2021-2030 (USD Million) Figure 60: Rest of Europe market, by End-User, 2021-2030 (USD Million) 11.3 Asia Pacific Figure 60: Asia Pacific Market, By Revenue Forecast (2021-2030) 11.3.1 Asia Pacific market, by country, 2021-2030 (USD Million) Table 18: Asia Pacific market, by country, 2021-2030 (USD Million) Figure 62: Asia Pacific market, by country, 2021-2030 (USD Million) 11.3.2 Asia Pacific market, By Technology, 2021-2030 (USD Million) Table 19: Asia Pacific market, By Technology, 2021-2030 (USD Million) Figure 63: Asia Pacific market, By Technology, 2021-2030 (USD Million) 11.3.3 Asia Pacific market, by End-User, 2021-2030 (USD Million) Table 20: Asia Pacific market, by End-User, 2021-2030 (USD Million) Figure 64: Asia Pacific market, by End-User, 2021-2030 (USD Million) 11.3.4 China 11.3.4.1 China market, By Technology, 2021-2030 (USD Million) Figure 65: China market, By Technology, 2021-2030 (USD Million) 11.3.4.2 China market, by End-User, 2021-2030 (USD Million) Figure 66: China market, by End-User, 2021-2030 (USD Million) 12.3.5 India 11.3.5.1 India market, By Technology, 2021-2030 (USD Million) Figure 67: India market, By Technology, 2021-2030 (USD Million) 11.3.5.2 India market, by End-User, 2021-2030 (USD Million) Figure 68: India market, by End-User, 2021-2030 (USD Million) 11.3.6 Japan 11.3.6.1 Japan market, By Technology, 2021-2030 (USD Million) Figure 69: Japan market, By Technology, 2021-2030 (USD Million) 11.3.6.2 Japan market, by End-User, 2021-2030 (USD Million) Figure 70: Japan market, by End-User, 2021-2030 (USD Million) 11.3.7 South Korea 11.3.7.1 South Korea market, By Technology, 2021-2030 (USD Million) Figure 71: South Korea market, By Technology, 2021-2030 (USD Million) 11.3.7.2 South Korea market, by End-User, 2021-2030 (USD Million) Figure 72: South Korea market, by End-User, 2021-2030 (USD Million) 11.3.8 Rest of APAC 11.3.8.1 Rest of APAC market, By Technology, 2021-2030 (USD Million) Figure 73: Rest of APAC market, By Technology, 2021-2030 (USD Million) 11.3.8.2 Rest of APAC market, by End-User, 2021-2030 (USD Million) Figure 74: Rest of APAC market, by End-User, 2021-2030 (USD Million) 11.4 Latin America Figure 75: Latin America Market, By Revenue Forecast (2021-2030) 11.4.1 Latin America market, by country, 2021-2030 (USD Million) Table 21: Latin America market, by country, 2021-2030 (USD Million) Figure 76: Latin America market, by country, 2021-2030 (USD Million) 11.4.2 Latin America market, By Technology, 2021-2030 (USD Million) Table 22: Latin America market, By Technology, 2021-2030 (USD Million) Figure 77: Latin America market, By Technology, 2021-2030 (USD Million) 11.4.3 Latin America market, by End-User, 2021-2030 (USD Million) Table 23: Latin America market, by End-User, 2021-2030 (USD Million) Figure 78: Latin America market, by End-User, 2021-2030 (USD Million) 11.4.4 Brazil 11.4.4.1 Brazil market, By Technology, 2021-2030 (USD Million) Figure 79: Brazil market, By Technology, 2021-2030 (USD Million) 11.4.4.2 Brazil market, by End-User, 2021-2030 (USD Million) Figure 80: Brazil market, by End-User, 2021-2030 (USD Million) 11.4.5 Mexico 11.4.5.1 Mexico market, By Technology, 2021-2030 (USD Million) Figure 81: Mexico market, By Technology, 2021-2030 (USD Million) 11.4.5 2 Mexico market, by End-User, 2021-2030 (USD Million) Figure 82: Mexico market, by End-User, 2021-2030 (USD Million) 11.4.6 Rest of the Latin America 11.4.6.1 Rest of the Latin America market, By Technology, 2021-2030 (USD Million) Figure 83: Rest of the Latin America market, By Technology, 2021-2030 (USD Million) 11.4.6.2 Rest of the Latin America market, by End-User, 2021-2030 (USD Million) Figure 84: Rest of the Latin America market, by End-User, 2021-2030 (USD Million) 11.5 MEA Figure 85: MEA Market, By Revenue Forecast (2021-2030) 11.5.1 MEA market, By Technology, 2021-2030 (USD Million) Figure 86: MEA market, By Technology, 2021-2030 (USD Million) 11.5.2 MEA market, by End-User, 2021-2030 (USD Million) Figure 87: MEA market, by End-User, 2021-2030 (USD Million) Chapter 12. Competitive Landscape 12.1 Neogen Corporation. 12.1.1 Company overview 12.1.2 Financial performance 12.1.3 Product Portfolio Analysis 12.1.4 Business Strategy & Recent Development 12.2 QIAGEN N.V. (A Part of Indical Bioscience). 12.2 .1 Company overview 12.2 .2 Financial performance 12.2 .3 Product Portfolio Analysis 12.2 .4 Business Strategy & Recent Development 12.3 Randox Laboratories, Ltd. 12.3.1 Company overview 12.3.2 Financial performance 12.3.3 Product Portfolio Analysis 12.3.4 Business Strategy & Recent Development 12.4 Thermo Fisher Scientific. 12.4.1 Company overview 12.4.2 Financial performance 1.4.3 Product Portfolio Analysis 12.4.4 Business Strategy & Recent Development 12.5 Virbac. 12.5.1 Company overview 12.5.2 Financial performance 12.5.3 Product Portfolio Analysis 12.5.4 Business Strategy & Recent Development 12.6 Biomerieux S.A.. 12.6.1 Company overview 12.6.2 Financial performance 12.6.3 Product Portfolio Analysis 12.6.4 Business Strategy & Recent Development 12.7 Heska Corporation. 12.7.1 Company overview 12.7.2 Financial performance 12.7.3 Product Portfolio Analysis 12.7.4 Business Strategy & Recent Development 12.8 IDEXX Laboratories, Inc. 12.8.1 Company overview 12.8.2 Financial performance 12.8.3 Product Portfolio Analysis 12.8.4 Business Strategy & Recent Development 12.9 IDVet. 12.9.1 Company overview 12.9.2 Financial performance 12.9.3 Product Portfolio Analysis 12.9.4 Business Strategy & Recent Development 12.10 Zoetis, Inc. 12.10.1 Company overview 12.10.2 Financial performance 12.10.3 Product Portfolio Analysis 12.10.4 Business Strategy & Recent Development